001     140619
005     20240430120009.0
024 7 _ |a 10.1038/s41420-019-0158-6
|2 doi
024 7 _ |a pmid:30886743
|2 pmid
024 7 _ |a pmc:PMC6411869
|2 pmc
024 7 _ |a altmetric:57930719
|2 altmetric
037 _ _ |a DZNE-2020-06941
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Schwintzer, Lukas
|0 P:(DE-2719)2810987
|b 0
|e First author
|u dzne
245 _ _ |a TRIAD3/RNF216 E3 ligase specifically synthesises K63-linked ubiquitin chains and is inactivated by mutations associated with Gordon Holmes syndrome.
260 _ _ |a London
|c 2019
|b Nature Publishing Group
264 _ 1 |3 online
|2 Crossref
|b Springer Science and Business Media LLC
|c 2019-03-11
264 _ 1 |3 print
|2 Crossref
|b Springer Science and Business Media LLC
|c 2019-12-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1714468365_8221
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a TRIAD3/RNF216 is a ubiquitin ligase of the RING-in-between-RING family. Recent publications identified TRIAD3 mutations in patients with neurological diseases, including Gordon Holmes syndrome and Huntington-like disorder. To understand the functional relevance of these disease-associated mutations, we have tested the ubiquitin ligase activity of mutated TRIAD3 in vitro. Several of these point mutations completely abrogated TRIAD3's catalytic activity. Using mass spectrometry, we identified new TRIAD3-interacting proteins/substrates from mouse brain lysate, which provide a new link between TRIAD3 and processes involving clathrin-mediated endocytosis. Strikingly, we found that TRIAD3 synthesises specifically lysine-63 (K63)-linked poly-ubiquitin chains in vitro, a chain type that usually plays a role in mediating signalling events rather than triggering proteasomal degradation. Therefore, this finding is of great importance to further understand TRIAD3's cellular role and loss-of-function in disease.
536 _ _ |a 341 - Molecular Signaling (POF3-341)
|0 G:(DE-HGF)POF3-341
|c POF3-341
|f POF III
|x 0
542 _ _ |i 2019-03-11
|2 Crossref
|u https://creativecommons.org/licenses/by/4.0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Aguado Roca, Eva
|0 P:(DE-2719)2810320
|b 1
|u dzne
700 1 _ |a Broemer, Meike
|0 P:(DE-2719)2810307
|b 2
|e Last author
|u dzne
773 1 8 |a 10.1038/s41420-019-0158-6
|b : Springer Science and Business Media LLC, 2019-03-11
|n 1
|p 75
|3 journal-article
|2 Crossref
|t Cell Death Discovery
|v 5
|y 2019
|x 2058-7716
773 _ _ |a 10.1038/s41420-019-0158-6
|g Vol. 5, no. 1, p. 75
|0 PERI:(DE-600)2842546-7
|n 1
|q 5:1<75
|p 75
|t Cell death discovery
|v 5
|y 2019
|x 2058-7716
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/140619/files/DZNE-2020-06941.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/140619/files/DZNE-2020-06941.pdf?subformat=pdfa
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411869
909 C O |o oai:pub.dzne.de:140619
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2810987
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2810320
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2810307
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-341
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Molecular Signaling
|x 0
914 1 _ |y 2019
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-03-31
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2021-02-14T16:19:13Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-03-31
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-03-31
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CELL DEATH DISCOV : 2021
|d 2023-03-31
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-03-31
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-03-31
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-02-14T16:19:13Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-02-14T16:19:13Z
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-03-31
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2023-03-31
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-03-31
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2021-02-14T16:19:13Z
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2023-03-31
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CELL DEATH DISCOV : 2021
|d 2023-03-31
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-03-31
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-03-31
920 1 _ |0 I:(DE-2719)5000021
|k AG Brömer 1
|l Ubiquitin-Mediated Processes in Neurodegenerative Diseases
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)5000021
980 1 _ |a FullTexts
999 C 5 |9 -- missing cx lookup --
|a 10.1038/ni1066
|2 Crossref
|o 10.1038/ni1066
999 C 5 |9 -- missing cx lookup --
|a 10.1371/journal.ppat.1000650
|2 Crossref
|o 10.1371/journal.ppat.1000650
999 C 5 |9 -- missing cx lookup --
|a 10.4161/15548627.2014.981792
|2 Crossref
|o 10.4161/15548627.2014.981792
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuron.2014.05.016
|2 Crossref
|o 10.1016/j.neuron.2014.05.016
999 C 5 |9 -- missing cx lookup --
|a 10.1056/NEJMoa1215993
|2 Crossref
|o 10.1056/NEJMoa1215993
999 C 5 |9 -- missing cx lookup --
|a 10.1111/acel.12551
|2 Crossref
|o 10.1111/acel.12551
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.0000000000001521
|2 Crossref
|o 10.1212/WNL.0000000000001521
999 C 5 |9 -- missing cx lookup --
|a 10.1038/cr.2016.39
|2 Crossref
|o 10.1038/cr.2016.39
999 C 5 |9 -- missing cx lookup --
|a 10.1146/annurev-biochem-060815-014922
|2 Crossref
|o 10.1146/annurev-biochem-060815-014922
999 C 5 |9 -- missing cx lookup --
|a 10.1038/s41594-018-0063-3
|2 Crossref
|o 10.1038/s41594-018-0063-3
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nature09966
|2 Crossref
|o 10.1038/nature09966
999 C 5 |9 -- missing cx lookup --
|a 10.1152/physiolgenomics.00226.2003
|2 Crossref
|o 10.1152/physiolgenomics.00226.2003
999 C 5 |9 -- missing cx lookup --
|a 10.1038/33416
|2 Crossref
|o 10.1038/33416
999 C 5 |9 -- missing cx lookup --
|a 10.1038/emboj.2011.204
|2 Crossref
|o 10.1038/emboj.2011.204
999 C 5 |9 -- missing cx lookup --
|a 10.1083/jcb.201402104
|2 Crossref
|o 10.1083/jcb.201402104
999 C 5 |9 -- missing cx lookup --
|a 10.1042/BJ20140334
|2 Crossref
|o 10.1042/BJ20140334
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nature13392
|2 Crossref
|o 10.1038/nature13392
999 C 5 |9 -- missing cx lookup --
|a 10.1126/science.1237908
|2 Crossref
|o 10.1126/science.1237908
999 C 5 |9 -- missing cx lookup --
|a 10.1038/sj.emboj.7601360
|2 Crossref
|o 10.1038/sj.emboj.7601360
999 C 5 |9 -- missing cx lookup --
|a 10.1038/emboj.2012.217
|2 Crossref
|o 10.1038/emboj.2012.217
999 C 5 |9 -- missing cx lookup --
|a 10.1093/nar/gky1131
|2 Crossref
|o 10.1093/nar/gky1131
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0092-8674(02)00735-3
|2 Crossref
|o 10.1016/S0092-8674(02)00735-3
999 C 5 |9 -- missing cx lookup --
|a 10.1034/j.1600-0854.2002.31006.x
|2 Crossref
|o 10.1034/j.1600-0854.2002.31006.x
999 C 5 |9 -- missing cx lookup --
|a 10.1083/jcb.200312034
|2 Crossref
|o 10.1083/jcb.200312034
999 C 5 |9 -- missing cx lookup --
|a 10.1091/mbc.e11-09-0817
|2 Crossref
|o 10.1091/mbc.e11-09-0817
999 C 5 |9 -- missing cx lookup --
|a 10.1242/jcs.00723
|2 Crossref
|o 10.1242/jcs.00723
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0968-0004(01)01835-7
|2 Crossref
|o 10.1016/S0968-0004(01)01835-7
999 C 5 |9 -- missing cx lookup --
|a 10.1146/annurev-biochem-051810-094654
|2 Crossref
|o 10.1146/annurev-biochem-051810-094654
999 C 5 |9 -- missing cx lookup --
|a 10.1091/mbc.e07-07-0678
|2 Crossref
|o 10.1091/mbc.e07-07-0678
999 C 5 |9 -- missing cx lookup --
|a 10.1038/s41598-017-18513-5
|2 Crossref
|o 10.1038/s41598-017-18513-5
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nprot.2015.018
|2 Crossref
|o 10.1038/nprot.2015.018
999 C 5 |9 -- missing cx lookup --
|a 10.1523/JNEUROSCI.20-11-03993.2000
|2 Crossref
|o 10.1523/JNEUROSCI.20-11-03993.2000
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuron.2006.09.031
|2 Crossref
|o 10.1016/j.neuron.2006.09.031
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuron.2006.08.034
|2 Crossref
|o 10.1016/j.neuron.2006.08.034
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nature16511
|2 Crossref
|o 10.1038/nature16511
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nature12638
|2 Crossref
|o 10.1038/nature12638
999 C 5 |9 -- missing cx lookup --
|a 10.1146/annurev-biochem-060310-170328
|2 Crossref
|o 10.1146/annurev-biochem-060310-170328
999 C 5 |9 -- missing cx lookup --
|a 10.1038/s41418-018-0164-x
|2 Crossref
|o 10.1038/s41418-018-0164-x
999 C 5 |9 -- missing cx lookup --
|a 10.1006/abio.1995.1010
|2 Crossref
|o 10.1006/abio.1995.1010
999 C 5 |9 -- missing cx lookup --
|a 10.1016/0003-2697(92)90061-B
|2 Crossref
|o 10.1016/0003-2697(92)90061-B
999 C 5 |9 -- missing cx lookup --
|a 10.1021/pr700600n
|2 Crossref
|o 10.1021/pr700600n
999 C 5 |9 -- missing cx lookup --
|a 10.1093/bioinformatics/btt703
|2 Crossref
|o 10.1093/bioinformatics/btt703


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21